查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1800762

2025 年至 2033 年细胞分析市场报告（按产品、分析类型、技术、最终用户和地区）

Cell Analysis Market Report by Product, Analysis Type, Techniques, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球细胞分析市场规模达222亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到412亿美元，2025-2033年期间的复合年增长率（CAGR）为7.1%。个人化医疗的转变、全球癌症病例的增加以及人工智慧和机器学习在细胞分析领域的日益融合，是推动市场成长的一些关键因素。

细胞分析市场分析：

  • 主要市场驱动因素：药物研发领域对细胞分析工具的需求不断增长，尤其是在肿瘤学和免疫学等领域，这主要推动了细胞分析市场规模的成长。癌症和自体免疫疾病等慢性疾病的发生率不断上升，也增加了对用于疾病诊断和治疗的先进细胞分析技术的需求，这也促进了市场的成长。
  • 主要市场趋势：再生医学和干细胞研究的扩展增加了对研究细胞行为、分化和治疗应用的细胞分析工具的需求，这为整个市场创造了积极的前景。
  • 竞争格局：全球市场上一些领先的细胞分析公司包括安捷伦科技公司、BD Biosciences、Bio-RAD Laboratories Inc.、丹纳赫公司、Illumina Inc.、默克公司、Miltenyi Biotec、奥林巴斯公司、珀金埃尔默公司、Promega 公司、Sysmex 公司和赛默飞尔科技公司等。
  • 地理趋势：报告显示，北美目前占据全球市场主导地位。该地区的成长可归因于癌症发生率的上升，以及企业和政府对细胞研究活动的资助增加。
  • 挑战与机会：挑战包括解读大规模资料的复杂性、分析过程中维持细胞活力以及先进技术的高成本。机会在于拓展个人化医疗、再生疗法以及人工智慧的整合应用，以增强分析能力并简化流程。

全球细胞分析市场趋势：

癌症负担日益加重

全球癌症病例的不断增加是推动市场成长的主要动力。癌症研究中的细胞分析工具和技术可以精确地表征肿瘤细胞，包括其基因突变、蛋白质表现谱以及肿瘤微环境内的细胞交互作用。癌症患者数量的不断增长正在催化细胞分析市场份额。例如，根据美国癌症协会 2022 年的最新消息，估计 2022 年美国将新增约 1,918,030 例癌症病例。此外，肺癌和乳癌是个人中最常见的两种癌症。加拿大癌症协会 (CCS) 表示，2020 年，近 29,800 名加拿大人被诊断出患有肺癌，占所有新癌症病例的 13%。预计约有 21,200 名加拿大人将死于肺癌，占 2020 年所有癌症死亡人数的 25%。这表明对有效和更先进的癌细胞分析的需求日益增长。因此，对有效和持久的癌症治疗的需求不断增加，预计将为整个市场提供丰厚的成长机会。

新型分子的开发日益增多

各种传染病的盛行率不断上升，促使新型分子和疫苗的研发，进而增加了细胞分析市场的收入。细胞分析工具在药物发现和开发中发挥至关重要的作用，使研究人员能够评估潜在候选药物的有效性、安全性和作用机制。此外，各种製药和生物技术公司越来越依赖细胞分析技术和工具来推出新的和改良的药物。例如，根据美国国会预算办公室 2021 年发布的资料，全球製药业在 2020 年的研发支出接近 2,000 亿美元，而 2019 年为 8,300 万美元。同样，丹纳赫公司在 2021 年的研发投资为 17.42 亿美元，而 2020 年为 13.48 亿美元。此外，Bio-Rad Laboratories Inc. 在 2021 年的投资为 8.796 亿美元，而 2020 年为 8.003 亿美元。因此，公司在研发方面不断增加的投资进一步提高了公司采用创新细胞分析技术的能力，从而推动了细胞分析市场的成长。

策略合作与收购数量不断增加

各大市场主要参与者正在建立合作伙伴关係，以开发新的和改进的细胞分析方法、工具和技术。例如，2022年8月，屡获殊荣的CellDrop自动细胞计数器製造商DeNovix Inc.开发了两款专用的细胞核计数应用程序，能够区分分离的细胞核、完整的细胞与细胞碎片。 CellDrop系列是基于影像的自动细胞计数器系列。系统配备7吋高清触控屏，可即时预览和即时查看结果。同样，索尼公司于2022年11月推出了SFA - 生命科学云平台，这是一种流式细胞资料分析云解决方案，可以利用流式细胞仪获取的资料，从各种细胞群中快速识别癌细胞和干细胞等稀有细胞。此外，赛默飞世尔科技于2022年3月推出了一款新型大容量电穿孔系统，旨在促进细胞疗法的开发。预计这些创新将在未来几年提振细胞分析市场的需求。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球细胞分析市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 流式细胞仪产品
  • qPCR产品
  • 细胞微阵列
  • 显微镜
  • 分光光度计
  • 细胞计数器
  • HCS系统
  • 其他的

第七章：市场区隔：依分析类型

  • 细胞识别
  • 细胞活力
  • 细胞讯息传递路径/讯号传导
  • 细胞增殖
  • 细胞计数和品质控制
  • 细胞交互作用
  • 目标识别与验证
  • 单细胞分析
  • 其他的

第八章：市场区隔：依技术

  • 分子方法
  • 基于影像的方法

第九章：市场区隔：依最终用户

  • 製药和生物技术公司及合约研究组织 (CRO)
  • 医院和诊断实验室
  • 研究机构
  • 细胞培养物保藏库
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • BD Biosciences
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Merck KGaA
    • Miltenyi Biotec
    • Olympus Corporation
    • PerkinElmer Inc.
    • Promega Corporation
    • Sysmex Corporation
    • Thermo Fisher Scientific
Product Code: SR112025A2200

The global cell analysis market size reached USD 22.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 41.2 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The shift towards personalized medicine, increasing cases of cancer across the globe, and growing integration of artificial intelligence and machine learning in cell analysis are some of the key factors, catalyzing the growth of the market.

Cell Analysis Market Analysis:

  • Major Market Drivers: Increasing demand for cell analysis tools in drug discovery and development, particularly in fields like oncology and immunology, is primarily boosting the cell analysis market size. The rising prevalence of chronic diseases like cancer and autoimmune disorders is augmenting the need for advanced cell analysis techniques for disease diagnosis and treatment, which is also contributing to the market growth.
  • Key Market Trends: The expansion of regenerative medicine and stem cell research is augmenting the need for cell analysis tools to study cell behavior, differentiation, and therapeutic applications, which is creating a positive outlook for the overall market.
  • Competitive Landscape: Some of the leading cell analysis companies operating in the global market include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, and Thermo Fisher Scientific, among others.
  • Geographical Trends: According to the report, North America currently dominates the global market. The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research activities.
  • Challenges and Opportunities: Challenges include the complexity of interpreting large-scale data, maintaining cell viability during analysis, and the high cost of advanced technologies. Opportunities lie in expanding applications in personalized medicines, regenerative therapies, and the integration of artificial intelligence to enhance analytical capabilities and streamline processes.

Global Cell Analysis Market Trends:

Growing Burden of Cancer

The rising number of cancer cases across the world is primarily driving the market growth. Cell analysis tools and techniques in cancer research enable precise characterization of tumor cells, including their genetic mutations, protein expression profiles, and cellular interactions within the tumor microenvironment. The growing number of cancer patients is catalyzing the cell analysis market share. For instance, as per an American Cancer Society 2022 update, around 1,918,030 new cancer cases were estimated in the U.S. in 2022. Furthermore, lung cancer and breast cancer are two of the most common cancers found among individuals. The Canadian Cancer Society (CCS) stated that in 2020, nearly 29,800 Canadians were diagnosed with lung cancer, which accounted for 13% of all new cancer cases. About 21,200 Canadians were expected to die from lung cancer, which represented 25% of all cancer deaths in 2020. This indicates an inflating need for effective and more advanced cancer cell analysis. Thus, the increasing demand for effective and lasting cancer treatment is anticipated to offer lucrative growth opportunities to the overall market.

Increasing Development of Novel Molecules

The rising prevalence of various infectious diseases is prompting the development of novel molecules and vaccines, which in turn is augmenting the cell analysis market revenue. Cell analysis tools play a crucial role in drug discovery and development by enabling researchers to assess the efficacy, safety, and mechanism of action of potential drug candidates. Furthermore, various pharmaceutical and biotech firms are increasingly relying on cell analysis techniques and tools to introduce new and improved drugs. For instance, according to the data published by the Congressional Budget Office, in 2021, it was observed that pharmaceutical industries spent nearly USD 200 Billion on research and development in 2020 globally, compared to USD 83 Million in 2019. Similarly, Danaher Corporation invested USD 1,742 Million in its research and development in 2021, as compared to USD 1,348 Million in 2020. In addition, Bio-Rad Laboratories Inc., invested USD 879.6 Million in 2021 as compared to USD 800.3 Million in 2020. Thus, the rising investment in research and development by the companies further increases the capabilities of the company to adopt innovative cell analysis techniques, thereby propelling the cell analysis market growth.

Rising Number of Strategic Collaborations and Acquisitions

Various key market players are forming partnerships and collaborations to develop new and improved cell analysis methods, tools, and techniques. For instance, in August 2022, DeNovix Inc., the manufacturer of the award-winning CellDrop Automated Cell Counter, developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris. The CellDrop Series is a line of image-based, automated cell counters. Systems include a high-definition 7-inch touchscreen for live preview and instant review of results. Similarly, in November 2022, Sony Corporation launched the SFA - Life Sciences Cloud Platform, a flow cytometry data analysis cloud solution that can quickly identify rare cells, such as cancer cells and stem cells, from a wide variety of cell populations, using data obtained from flow cytometers. In addition to this, in March 2022, Thermo Fisher Scientific introduced a new large-volume electroporation system that is intended to enable the development of cell therapies. Such innovations are expected to bolster the cell analysis market demand in the coming years.

Global Cell Analysis Industry Segmentation:

Breakup by Product:

  • Flow Cytometry Products
  • qPCR Products
  • Cell Microarrays
  • Microscopes
  • Spectrophotometers
  • Cell Counters
  • HCS Systems
  • Others

Flow cytometry products exhibit a clear dominance in the market

The cell analysis market report has provided a detailed breakup and analysis of the market based on the product. This includes flow cytometry products, qPCR Products, cell microarrays, microscopes, spectrophotometers, cell counters, HCS systems, and others. According to the report, flow cytometry products exhibit a clear dominance in the market.

Flow cytometry products are pivotal in the cell analysis market, offering precise quantification and characterization of cells based on their physical and chemical properties. Key components include flow cytometers, which analyze cells in fluid suspension using lasers to detect fluorescently labeled cells. Reagents such as fluorescent dyes and antibodies enable specific labeling for biomarker detection, while software facilitates data analysis and visualization. These products are essential in research, clinical diagnostics, and drug discovery, providing insights into cell function, differentiation, and disease mechanisms. Ongoing advancements in technology are enhancing sensitivity, multiplexing capabilities, and automation, expanding the utility of flow cytometry in diverse biomedical applications.

Breakup by Analysis Type:

  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways/Signal Transduction
  • Cell Proliferation
  • Cell Counting and Quality Control
  • Cell Interaction
  • Target Identification and Validation
  • Single-Cell Analysis
  • Others

Cell identification analysis type holds the majority of the total market share

The cell analysis market research report has provided a detailed breakup and analysis of the market based on the analysis type. This includes cell identification, cell viability, cell signaling pathways/signal transduction, cell proliferation, cell counting and quality control, cell interaction, target identification and validation, single-cell analysis, and others. According to the report, cell identification analysis type holds the majority of the total market share.

Cell identification in cell analysis involves various techniques to distinguish and classify cells based on their morphological, molecular, or functional characteristics. Methods include microscopy for visual inspection, flow cytometry for quantitative analysis of cell surface markers, and molecular techniques like PCR for genetic profiling. Immunohistochemistry and immunofluorescence enable detection of specific proteins within tissues or cell samples. Advances in single-cell analysis technologies allow for high-resolution characterization of individual cells within heterogeneous populations. Accurate cell identification is crucial in understanding disease mechanisms, assessing treatment responses, and advancing personalized medicine by tailoring therapies based on individual cell profiles.

Breakup by Techniques:

  • Molecular Approaches
  • Image-Based Approaches

Molecular approaches represent the largest market share

Molecular approaches in cell analysis focus on studying cellular components at the molecular level to understand biological processes and diseases. Techniques include PCR (Polymerase Chain Reaction) for amplifying and detecting DNA or RNA sequences, Western blotting for protein detection and quantification, and next-generation sequencing (NGS) for comprehensive genomic analysis. These methods enable researchers to investigate gene expression, mutations, protein interactions, and epigenetic modifications within cells. Molecular approaches are vital in biomarker discovery, drug development, and personalized medicine, offering insights into cellular function and disease mechanisms with high sensitivity and specificity. Continued advancements enhance their utility in diverse biomedical research applications.

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies and CROs
  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Cell Culture Collection Repositories
  • Others

Pharmaceutical and biotechnology companies and CROs currently account for the majority of the total market share

Pharmaceutical and biotechnology companies develop and commercialize drugs and therapies for medical use. They conduct extensive research and clinical trials to discover new compounds, validate their efficacy and safety, and obtain regulatory approvals. Contract Research Organizations (CROs) support these efforts by providing specialized, such as clinical trial management, data analysis, and regulatory compliance. CROs enable companies to outsource non-core activities, accelerate timelines, and manage costs effectively. Furthermore, the increasing rate of new drug development is also contributing to the segment's growth. For instance, between 2010 and 2019, around 38 new drugs were approved each year, on an average. That is about a 60% increase compared with the previous decade. Drug approvals reached a new peak in 2018, surpassing the record number of approvals of the late 1990s. The cell analysis market statistics by IMARC indicate that together, pharmaceutical/biotech firms and CROs are playing crucial roles in advancing healthcare innovation, bringing new treatments to market, and improving patient outcomes through rigorous scientific research and development.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America currently dominates the global market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

The growth of the region can be attributed to the increase in incidences of cancer and rising corporate and government funding in cell-based research. For instance, according to the Canadian Cancer Statistics 2022 Special Report, the number of people living with and after cancer in Canada continued to grow to over 1.5 million people. Additionally, according to another report, 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime. Approximately 1 in 4 Canadians is expected to die of the disease. Besides this, the presence of major companies, the growing number of product launches, and the strong R&D in biotechnology are further positively impacting the cell analysis market outlook. For instance, in September 2022, Becton, Dickinson, and Company launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher-quality experiments with faster time to insight for scientists working across a range of disciplines, including immunology, virology, oncology, and infectious disease monitoring.

Competitive Landscape:

The competitive landscape of the industry has also been examined with the detailed profiles of the following key players:

  • Agilent Technologies Inc.
  • BD Biosciences
  • Bio-RAD Laboratories Inc.
  • Danaher Corporation
  • Illumina Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • Olympus Corporation
  • PerkinElmer Inc.
  • Promega Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific

Key Questions Answered in This Report

  • 1.How big is the cell analysis market?
  • 2.What is the expected growth rate of the global cell analysis market during 2025-2033?
  • 3.What are the key factors driving the global cell analysis market?
  • 4.What has been the impact of COVID-19 on the global cell analysis market?
  • 5.What is the breakup of the global cell analysis market based on the product?
  • 6.What is the breakup of the global cell analysis market based on the analysis type?
  • 7.What is the breakup of the global cell analysis market based on the techniques?
  • 8.What is the breakup of the global cell analysis market based on the end-user?
  • 9.What are the key regions in the global cell analysis market?
  • 10.Who are the key players/companies in the global cell analysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Analysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Flow Cytometry Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 qPCR Products
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Microarrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microscopes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Spectrophotometers
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Cell Counters
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 HCS Systems
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Analysis Type

  • 7.1 Cell Identification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell Viability
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cell Signaling Pathways/Signal Transduction
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cell Proliferation
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cell Counting and Quality Control
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Cell Interaction
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Target Identification and Validation
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Single-Cell Analysis
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Techniques

  • 8.1 Molecular Approaches
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Image-Based Approaches
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotechnology Companies and CROs
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cell Culture Collection Repositories
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 BD Biosciences
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Miltenyi Biotec
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Olympus Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 PerkinElmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Promega Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sysmex Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Analysis Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Analysis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cell Analysis Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Cell Analysis Market: Breakup by Analysis Type (in %), 2024
  • Figure 5: Global: Cell Analysis Market: Breakup by Techniques (in %), 2024
  • Figure 6: Global: Cell Analysis Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Cell Analysis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cell Analysis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Cell Analysis (Flow Cytometry Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cell Analysis (Flow Cytometry Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cell Analysis (qPCR Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cell Analysis (qPCR Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cell Analysis (Cell Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cell Analysis (Cell Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cell Analysis (Microscopes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cell Analysis (Microscopes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cell Analysis (Spectrophotometers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cell Analysis (Spectrophotometers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cell Analysis (Cell Counters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cell Analysis (Cell Counters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cell Analysis (HCS Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cell Analysis (HCS Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cell Analysis (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cell Analysis (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cell Analysis (Cell Identification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cell Analysis (Cell Identification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cell Analysis (Cell Viability) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cell Analysis (Cell Viability) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cell Analysis (Cell Signaling Pathways/Signal Transduction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Cell Analysis (Cell Proliferation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Cell Analysis (Cell Proliferation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Cell Analysis (Cell Counting and Quality Control) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Cell Analysis (Cell Counting and Quality Control) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Cell Analysis (Cell Interaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Cell Analysis (Cell Interaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Cell Analysis (Target Identification and Validation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Cell Analysis (Target Identification and Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Cell Analysis (Single-Cell Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Cell Analysis (Single-Cell Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Cell Analysis (Other Analysis Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Cell Analysis (Other Analysis Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Cell Analysis (Molecular Approaches) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Cell Analysis (Molecular Approaches) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Cell Analysis (Image-Based Approaches) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Cell Analysis (Image-Based Approaches) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Cell Analysis (Pharmaceutical and Biotechnology Companies and CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Cell Analysis (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Global: Cell Analysis (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Global: Cell Analysis (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Global: Cell Analysis (Cell Culture Collection Repositories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Global: Cell Analysis (Cell Culture Collection Repositories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Global: Cell Analysis (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Global: Cell Analysis (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: North America: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: North America: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United States: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United States: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Canada: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Canada: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Asia Pacific: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Asia Pacific: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: China: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: China: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Japan: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Japan: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: India: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: India: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: South Korea: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: South Korea: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Australia: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Australia: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Indonesia: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Indonesia: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Europe: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Europe: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Germany: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Germany: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: France: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: France: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: United Kingdom: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: United Kingdom: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Italy: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Italy: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Spain: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Spain: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Russia: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Russia: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Others: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Others: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Latin America: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Latin America: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Brazil: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Brazil: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 99: Mexico: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 100: Mexico: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Others: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 102: Others: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 103: Middle East and Africa: Cell Analysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 104: Middle East and Africa: Cell Analysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 105: Global: Cell Analysis Industry: SWOT Analysis
  • Figure 106: Global: Cell Analysis Industry: Value Chain Analysis
  • Figure 107: Global: Cell Analysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Analysis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cell Analysis Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Cell Analysis Market Forecast: Breakup by Analysis Type (in Million USD), 2025-2033
  • Table 4: Global: Cell Analysis Market Forecast: Breakup by Techniques (in Million USD), 2025-2033
  • Table 5: Global: Cell Analysis Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Cell Analysis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Cell Analysis Market: Competitive Structure
  • Table 8: Global: Cell Analysis Market: Key Players